This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Century Aluminum (CENX) upgraded to Peer Perform from Underperform at Wolfe Research
> Esperion Therapeutics (ESPR) upgraded to Buy from Hold at Jefferies; tgt $12
> Grainger (GWW) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt raised to $679
> LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $130
> NeoGenomics (NEO) upgraded to Buy from Hold at The Benchmark Company; tgt $20
> Youdao (DAO) upgraded to Buy from Hold at Jefferies; tgt raised to $10
Downgrades:
> C4 Therapeutics (CCCC) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $5
> CURO Group (CURO) downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $4
> Moderna (MRNA) downgraded to Underperform from Market Perform at SVB Securities; tgt lowered to $93
> Nektar Therapeutics (NKTR) downgraded to Underperform from Hold at Jefferies; tgt lowered to $1.50
> New York Mortgage Trust (NYMT) downgraded to Neutral from Buy at Ladenburg Thalmann
> OGE Energy (OGE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $39
Others:
> Biomea Fusion (BMEA) initiated with a Buy at Citigroup; tgt $20
> Erasca (ERAS) initiated with a Buy at Goldman; tgt $10
> KE Holdings (BEKE) initiated with a Buy at Daiwa Securities
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
